Abstract Body

Guidelines recommend use of combination neonatal prophylaxis (CNP) with 2 or 3 drugs in specific high risk situations. Data on safety of neonatal prophylaxis (NP), particularly CNP, are limited. Our aim was to identify whether NP type is associated with 1) severe or potentially life-threatening anaemia or neutropenia in the first 6 months of life and 2) haemoglobin (Hb) level and neutrophil count (NC) at ages 0-18 months.

An individual patient-data meta-analysis was conducted within 6 cohorts. Infants born 01/01/96 to 30/06/10, at high risk for acquiring HIV (defined according to US Guidelines) and with HIV status, Hb and NC measures available were included. CNP was defined as ≥2 antiretrovirals given for PMTCT. Hb and NC were graded using 2004 DAIDS paediatric toxicity tables. Adjusted logistic regression models assessing risk of grade 3-4 anaemia / neutropenia in the first 6 months of life included cohort, period, infant HIV and in utero ART exposure a priori. Mixture models of 1) Hb levels and 2) log10-transformed NC were conducted to explore associations with NP type at ages 0-18 months.

Of the 1836 infants (969 male), 468 (25%) were preterm (<37 weeks), 1149 (63%) had been exposed to antenatal cART and 398 (22%) received CNP (126 with 3 drugs). Median duration was 5.7 weeks for 1 drug NP and 5.9 weeks for CNP. Overall, 117 (6.7%) infants had Grade 3-4 anaemia at age 0-6 months and 140 (9.1%) had Grade 3-4 neutropenia (Table). Grade 3-4 anaemia was not associated with NP type (AOR 1.09 for 1 drug and 1.70 for 3 drugs vs 2 drug NP, p>0.05), but was with preterm delivery (AOR 1.86 for 33-36 and 2.68 for ≤32 weeks vs term) and in utero ART exposure (data not shown).  Infants receiving no NP had increased risk of grade 3-4 neutropenia (AOR 3.26 vs 2 drug NP, p=0.04), as did severe preterm (≤32w) infants (AOR 2.55 vs term, p=0.006). Overall 7746 Hb and NC results were available for 1836 infants up to age 18 months; no significant differences in predicted Hb levels or NC were apparent by NP type (Hb: coefficient -0.189 [95%CI -0.38,0.007], p=0.060; NC: 0.021 [95%CI -0.012, 0.055], p=0.218).

A small proportion of infants experienced grade 3-4 haematological toxicity in their first 6 months of life; risk of anaemia was not associated with type of NP exposure in adjusted analysis, whilst among infants receiving NP, there was no significant difference in risk of neutopenia by number of NP drugs.